Dr Shi Yin Foo joins the Board as a Non-Executive Director (NED), while Dr Gary Burgess is confirmed as Chief Medical Officer (CMO). Both bring extensive experience in the cardiovascular drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback